“If they take it without knowing, they will default…”: perceptions of targeted information transfer to promote adherence to intermittent preventive treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy in western Kenya
Jenna Hoyt, Hellen C Barsosio, Isdorah A Odero, Benson Omondi, Florence Achieng, Simon Kariuki, Jenny Hill, Jayne Webster · 2024
Read “If they take it without knowing, they will default…”: perceptions of targeted information transfer to promote adherence to intermittent preventive treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy in western Kenya by Jenna Hoyt, Hellen C Barsosio, Isdorah A Odero, Benson Omondi, Florence Achieng, Simon Kariuki, Jenny Hill, Jayne Webster (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605956.txt.
Description
Eight authors present a study from two thousand twenty-four on why a malaria prevention drug for pregnant women needs good explanation. In pregnancy, malaria is prevented by scheduled doses, but the standard drug is losing power to resistance. The leading replacement works, yet its course runs over several days, and even single-dose uptake is low.
A Kenyan trial found adherence rose when the drug came with a targeted information package: provider training plus communication tools. The authors interviewed health workers and pregnant women to learn how that package changed behavior. The title quotes the worry that women who swallow pills unknowingly may stop.
Catalog record
| CREATOR | Jenna Hoyt, Hellen C Barsosio, Isdorah A Odero, Benson Omondi, Florence Achieng, Simon Kariuki, Jenny Hill, Jayne Webster |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |